Tjønnfjord GE - Search Results

1

Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients.

Berentsen S, Ulvestad E, Gjertsen BT, Hjorth-Hansen H, Langholm R, Knutsen H, Ghanima W, Shammas FV, Tjønnfjord GE. Berentsen S, et al. Among authors: tjonnfjord ge. Blood. 2004 Apr 15;103(8):2925-8. doi: 10.1182/blood-2003-10-3597. Epub 2003 Dec 30. Blood. 2004. PMID: 15070665 Free article. Clinical Trial.

2

No response to cladribine in five patients with chronic cold agglutinin disease.

Berentsen S, Tjønnfjord GE, Shammas FV, Bergheim J, Hammerstrøm J, Langholm R, Ulvestad E. Berentsen S, et al. Among authors: tjonnfjord ge. Eur J Haematol. 2000 Jul;65(1):88-90. doi: 10.1034/j.1600-0609.2000.9l201.x. Eur J Haematol. 2000. PMID: 10914950 No abstract available.

3

New strategies in the treatment of acute myelogenous leukemia: mobilization and transplantation of autologous peripheral blood stem cells in adult patients.

Bruserud O, Tjønnfjord G, Gjertsen BT, Foss B, Ernst P. Bruserud O, et al. Stem Cells. 2000;18(5):343-51. doi: 10.1634/stemcells.19-1-1. Stem Cells. 2000. PMID: 11007918 Review.

4

Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease.

Berentsen S, Tjønnfjord GE, Brudevold R, Gjertsen BT, Langholm R, Løkkevik E, Sørbø JH, Ulvestad E. Berentsen S, et al. Among authors: tjonnfjord ge. Br J Haematol. 2001 Oct;115(1):79-83. doi: 10.1046/j.1365-2141.2001.03078.x. Br J Haematol. 2001. PMID: 11722415 Free article.

5

[Hairy cell leukemia treated with cladribine].

Ghanima W, Heldal D, Tjønnfjord GE. Ghanima W, et al. Among authors: tjonnfjord ge. Tidsskr Nor Laegeforen. 2002 Apr 30;122(11):1094-7. Tidsskr Nor Laegeforen. 2002. PMID: 12043051 Free article. Norwegian.

6

Sustained cytogenetic response after discontinuation of imatinib mesylate in a patient with chronic myeloid leukaemia.

Ghanima W, Kahrs J, Dahl TG 3rd, Tjonnfjord GE. Ghanima W, et al. Among authors: tjonnfjord ge. Eur J Haematol. 2004 Jun;72(6):441-3. doi: 10.1111/j.1600-0609.2004.00257.x. Eur J Haematol. 2004. PMID: 15128424

7

Primary chronic cold agglutinin disease: a population based clinical study of 86 patients.

Berentsen S, Ulvestad E, Langholm R, Beiske K, Hjorth-Hansen H, Ghanima W, Sørbø JH, Tjønnfjord GE. Berentsen S, et al. Among authors: tjonnfjord ge. Haematologica. 2006 Apr;91(4):460-6. Haematologica. 2006. PMID: 16585012

8

Primary chronic cold agglutinin disease: an update on pathogenesis, clinical features and therapy.

Berentsen S, Beiske K, Tjønnfjord GE. Berentsen S, et al. Among authors: tjonnfjord ge. Hematology. 2007 Oct;12(5):361-70. doi: 10.1080/10245330701445392. Hematology. 2007. PMID: 17891600 Free PMC article. Review.

9

B-lymphocytes as targets for therapy in chronic cold agglutinin disease.

Berentsen S, Ulvestad E, Tjønnfjord GE. Berentsen S, et al. Among authors: tjonnfjord ge. Cardiovasc Hematol Disord Drug Targets. 2007 Sep;7(3):219-27. doi: 10.2174/187152907781745279. Cardiovasc Hematol Disord Drug Targets. 2007. PMID: 17896962 Review.

10

[Autoimmune hemolytic anemia].

Berentsen S, Sundic T, Hervig T, Tjønnfjord GE. Berentsen S, et al. Among authors: tjonnfjord ge. Tidsskr Nor Laegeforen. 2009 Nov 5;129(21):2226-31. doi: 10.4045/tidsskr.09.0161. Tidsskr Nor Laegeforen. 2009. PMID: 19898570 Free article. Review. Norwegian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

233 results

Search Page